Dr. June’s #AACR26 update on Neuroendocrine lineage plasticity is a masterclass in complexity. The traditional move? Add more CDs to track the transition.
But what if the answer isn't more labels, but zero? #deepcell #golabelfree
Catch #EJuneOlag 's poster at #AACR2026 — Monday 4/20, 2–5 PM, Poster Section 46, Board #3 (Poster 3870).
She's using Deepcell to explore molecular classification and tumor biology. Abstract #7200 if you want to read ahead.
Spot her, say hi 👇
Replying to @vttang1126
@vttang1126 sharing how applying transformer architecture to large pathology slides would be computationally an cost-wise prohibitive.
Deepcell retweeted
Replying to @vttang1126
@vttang1126 sharing how applying transformer architecture to large pathology slides would be computationally an cost-wise prohibitive.
Dr heckman of FIMM: 1) They first realized different cell types from the same AML patient respond differently to different drugs. 2) They conjectured therefore morphology can differentiate different drug response. 3) Then they validated that with Deepcell.
Dr. Rivera: We were able to see significant difference in various morphological features between healthy cells, aging cells, passage cell etc.
Dr Jeanne Rivera of NML re cell quality assessment: What Deepcell identified was beyond viability marker detection.
Upcoming webinar announcement Nov 4 9AM ET : Dr. Caroline Heckman (FIMM), a global leader in precision oncology:
✨ “How Morphology Links to Drug Response in AML, with Practical Analysis Workflows:
share.hsforms.com/1AiQ8fMgcT…
A transplanted organ saves a life—but keeping it safe often means puncturing it, repeatedly. See our work with @ErasmusMC that can change that into a blood test in comments below.
youtube.com/watch?v=Kx6Qka5B…
At Erasmus MC, cardiologist Dr. Olivier Manintveld and his team are exploring a new path: replacing much of the hashtag#biopsy burden with something simpler and more humane: a non-invasive blood draw guided by hashtag#AI.
Using Deepcell’s #REM-I, Erasmus MC is mapping millions of immune cells directly from blood, label-free, and uncovering subtle signatures of rejection before they become clinical crises.
This is the start of a journey to reimagine that from puncture to pulse-checking
oday, our President & CTO @mahyarsalek took the main stage at #SuperAI2025 #Singapore to deliver a bold vision:
AI isn’t just accelerating biology, it’s changing how we think about life itself.
Spotlight on #BioIntelligence at #superAI Singapore!
Our President & CTO @mahyarsalek took the main stage alongside @munjalshah ( @hippocraticai ) and @AlexAliper (Insilico Medicine), with @alitamaseb of DCVC
Deepcell Announces Collaboration with @MayoClinic to Advance AI-Driven IVF Technology. Link in the comments.











